Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 Highlights
Zanidatamab Demonstrates Efficacy in Refractory HER2-Amplified Biliary Tract Cancer
Emerging Therapies
,
ASCO 2023 Highlights
October 2023, Vol 14, No 5
Improving clinical outcomes in the second line of treatment in patients with advanced biliary tract cancer remains an important goal, and researchers have been exploring various therapeutic targets, including
HER2
, an oncogene that creates a protein that encourages cell growth and accelerates the spread of cancers.
Read Article
AMA Examines Decade of Change in Physician Practice Ownership and Organization
Healthcare Administration
October 2023, Vol 14, No 5
Chicago, IL—Physicians are less likely to work in a private practice than 10 years ago due to economic, administrative, and regulatory burdens that have driven physicians to shift traditional business models for medical practices, according to a newly released biennial analysis of physician practice arrangements by the American Medical Association.
Read Article
Updated ASCO Guidelines Reiterate the Importance of Geriatric Assessment in Older Patients With Cancer
Oncology Practice
,
ASCO 2023 Highlights
,
Geriatric Cancer
,
ASCO
October 2023, Vol 14, No 5
The American Society of Clinical Oncology has issued an update to its guidelines for the practical assessment and management of vulnerabilities in patients aged ≥65 years receiving systemic cancer treatment.
Read Article
Study Shows How Morphine May Contribute to Bone Loss and Cancer-Induced Bone Pain
Symptom Management
Online First
Opioids such as morphine are the gold standard for treating cancer-induced bone pain, but new University of Arizona Health Sciences research recently published in
PAIN
uncovered a mechanism by which chronic morphine use may increase bone loss and pain.
Read Article
Why Your Claims Are Getting Denied—and What to Do About It
By
Juan Arredondo
;
Bri Driggers
Reimbursement
Online First
Medicine is an essential service. Yet, healthcare providers still need to make enough profit to cover their overhead costs if they want to keep their doors open. That is why it is essential for your business and community that claims are processed accurately and that you get reimbursed for your services.
Read Article
Bringing Stakeholders Together Bringing Stakeholders Together
Videos
For executives like Andrew Hertler, MD, FACP, CMO, New Century Health, the annual AVBCC Educational Summit & Program is the single best conference for meeting with a large number of peers simultaneously.
Read Article
Improving Diversity in Clinical Trials
By
Phoebe Starr
Disparities in Cancer Care
,
ASCO 2023 Highlights
August 2023, Vol 14, No 4
Chicago, IL—It is well documented that clinical trials thus far have for the most part excluded underserved populations, and that means the results of these trials cannot be generalized to society at large. Fortunately, the federal government and medical societies have taken aim at remedying this imbalance in accrual for clinical trials.
Read Article
Survey Offers Snapshot of Patient and Provider Perceptions of AI Use in Healthcare
Healthcare Technology
August 2023, Vol 14, No 4
Have you ever asked ChatGPT to create a bio on yourself? Was it spot-on? Somewhat accurate? Total fiction? ChatGPT and similar programs, such as Google’s Med-PaLM 2 and Bard, and Microsoft’s Bing Chat, are generative artificial intelligence (AI) programs that use large language models to respond to prompts.
Read Article
Partnering With Patients Key to Improving Healthcare Outcomes
By
Phoebe Starr
ASCO 2023 Highlights
August 2023, Vol 14, No 4
Chicago, IL—The presidential theme for the 2023 American Society of Clinical Oncology Annual Meeting was “Partnering With Patients: The Cornerstone of Clinical Care and Research.”
Read Article
Ribociclib Plus Endocrine Therapy Improves Invasive Disease-Free Survival in Patients With HR-Positive, HER2-Negative, Early Breast Cancer
By
Phoebe Starr
ASCO 2023 Highlights
,
Breast Cancer
August 2023, Vol 14, No 4
Chicago, IL—The addition of the CDK4/6 inhibitor ribociclib (Kisqali) to endocrine therapy significantly improved invasive disease-free survival in patients with hormone receptor (HR)-positive,
HER2
-negative, early breast cancer, according to interim results from the phase 3 NATALEE trial, which were presented at the 2023 American Society of Clinical Oncology Annual Meeting.
Read Article
Page 10 of 330
7
8
9
10
11
12
13
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Gaps in Biomarker Testing and Targeted Therapy for Gastric Cancer
Ashley Gamble, PhD
,
John Perez, MBA, MSDS
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma